About
Scott Shandler, PhD, MBA, is the co-founder and CEO of Longevity Biotech, a Philadelphia-based company developing precision neuroscience and peptide-based therapeutics for neurodegenerative disease, especially Parkinson's disease. The Michael J. Fox Foundation lists him as a CEO and principal investigator on multiple Parkinson's-related funded studies. Before founding Longevity Biotech, he worked at BioAdvance, Merck Research Labs, PolyMedix, Accenture, and Inventa.
Areas of interest
longevitybiotechneurodegenerative diseaseParkinson's diseaseprecision neurosciencetherapeuticsdrug developmentimmunomodulationdiagnosticsbiomarkers